Oramed Pharmaceuticals
ORMP
ORMP
25 hedge funds and large institutions have $3.83M invested in Oramed Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less capital invested
Capital invested by funds: $5.7M → $3.83M (-$1.86M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
25
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$169K | |
| 2 | +$38K | |
| 3 | +$36.5K | |
| 4 |
CAM
Close Asset Management
London,
United Kingdom
|
+$26.3K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$13.4K |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$916K | |
| 3 | -$231K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$55K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$51K |